GTC Biotherapeutics (fka GTCB)

[shears]

It seems to me the key to this deal is what else besides Factor VIIa is availble to profit on and how long will these other proteins take to get to market? Having a larger share of this potential market revenue is great and if Factor VIIa is just the start then I'm happy. If the whole deal is just for Factor VII (and hopefully maybe something else) it doesn't make much sense to me. I don't see a huge market there. I think management could allude to future prospects (a little more concretely) without tipping their hand on the particulars. I will definately hold the shares I have but I can't justify buying more without better information on why selling this much of the company makes sense without a better understanding of what is being gained. It would be nice to see some deals struck in the future for contract manufacturing that don't require further dilution and provide a more robust revenue stream going forward.